Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$20.78 -1.24 (-5.63%)
Closing price 04:00 PM Eastern
Extended Trading
$20.82 +0.04 (+0.21%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLFS vs. SLNO, TMDX, INSP, NVST, PRCT, WRBY, LIVN, EYE, NVCR, and LMAT

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), NovoCure (NVCR), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.

BioLife Solutions vs. Its Competitors

BioLife Solutions (NASDAQ:BLFS) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

In the previous week, Soleno Therapeutics had 5 more articles in the media than BioLife Solutions. MarketBeat recorded 17 mentions for Soleno Therapeutics and 12 mentions for BioLife Solutions. Soleno Therapeutics' average media sentiment score of 0.83 beat BioLife Solutions' score of 0.41 indicating that Soleno Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioLife Solutions
4 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Soleno Therapeutics
5 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 6.4% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BioLife Solutions has higher revenue and earnings than Soleno Therapeutics. BioLife Solutions is trading at a lower price-to-earnings ratio than Soleno Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLife Solutions$82.25M12.08-$20.18M-$0.29-71.66
Soleno TherapeuticsN/AN/A-$175.85M-$4.62-18.09

BioLife Solutions has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.63, meaning that its share price is 363% less volatile than the S&P 500.

BioLife Solutions currently has a consensus target price of $31.17, indicating a potential upside of 49.98%. Soleno Therapeutics has a consensus target price of $108.70, indicating a potential upside of 30.04%. Given BioLife Solutions' higher probable upside, equities research analysts clearly believe BioLife Solutions is more favorable than Soleno Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLife Solutions
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Soleno Therapeutics
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09

Soleno Therapeutics has a net margin of 0.00% compared to BioLife Solutions' net margin of -11.81%. BioLife Solutions' return on equity of -0.66% beat Soleno Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BioLife Solutions-11.81% -0.66% -0.58%
Soleno Therapeutics N/A -77.52%-63.44%

Summary

Soleno Therapeutics beats BioLife Solutions on 8 of the 15 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.05B$10.09B$5.53B$9.30B
Dividend YieldN/A2.08%4.59%4.03%
P/E RatioN/A16.6928.5619.60
Price / Sales12.0828.24359.9473.66
Price / Cash179.7423.5224.7327.56
Price / Book2.763.598.155.55
Net Income-$20.18M$233.40M$3.24B$257.73M
7 Day Performance-7.85%-1.64%2.03%0.95%
1 Month Performance-5.67%2.77%8.29%10.68%
1 Year Performance-0.10%-17.92%28.40%15.67%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
2.1702 of 5 stars
$20.78
-5.6%
$31.17
+50.0%
+6.3%$1.05B$82.25M0.00440
SLNO
Soleno Therapeutics
4.5712 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+73.6%$4.17BN/A-17.9130High Trading Volume
TMDX
TransMedics Group
2.2901 of 5 stars
$116.88
+3.9%
$127.33
+8.9%
-17.8%$3.95B$441.54M85.94210Positive News
Analyst Forecast
INSP
Inspire Medical Systems
4.8709 of 5 stars
$130.17
-0.1%
$211.91
+62.8%
-6.3%$3.84B$802.80M59.981,246Positive News
Analyst Upgrade
NVST
Envista
3.2286 of 5 stars
$20.05
-0.8%
$20.23
+0.9%
+25.0%$3.40B$2.51B-3.0712,300
PRCT
PROCEPT BioRobotics
2.2755 of 5 stars
$58.17
+2.7%
$87.50
+50.4%
-16.1%$3.22B$249.12M-34.22430News Coverage
Analyst Downgrade
WRBY
Warby Parker
2.4651 of 5 stars
$23.02
+3.7%
$22.88
-0.6%
+42.2%$2.41B$795.09M-191.803,780News Coverage
Positive News
LIVN
LivaNova
3.1098 of 5 stars
$43.97
-0.8%
$59.29
+34.8%
-14.5%$2.40B$1.25B-10.752,900Positive News
EYE
National Vision
2.6688 of 5 stars
$25.01
+2.2%
$22.10
-11.6%
+97.4%$1.98B$1.82B-75.7913,411Analyst Upgrade
NVCR
NovoCure
3.5258 of 5 stars
$17.42
-1.0%
$32.43
+86.2%
-3.1%$1.94B$605.22M-11.541,488
LMAT
LeMaitre Vascular
2.2997 of 5 stars
$84.09
+0.5%
$97.83
+16.3%
-2.3%$1.90B$226.26M42.47490News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners